Awareness, Care & Treatment In Obesity Management - An International Observation Among Teens (ACTION Teens) (ACTION Teens)

February 1, 2022 updated by: Novo Nordisk A/S

ACTION Teens is a multinational cross-sectional survey-based study. The study consists of a quantitative online survey to be conducted among three groups of respondents in ten countries worldwide. The respondent population will include Adolescents Living with Obesity (ALwO), Caregivers of ALwO, and HCPs treating adolescents who have obesity.

The goal of this study is to provide insights to drive awareness around the needs of adolescents living with obesity and their caregivers, as well as to identify key areas of misalignment between adolescents, their caregivers and the HCPs involved in obesity treatment and management. ACTION Teens is designed to generate evidence to identify and address these challenges on both a global and local level, extending the insights from the previously conducted ACTION-IO study.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

12987

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Sydney, Australia, NSW 2060
        • Novo Nordisk Investigational Site
      • Bogotá, Colombia, 110111
        • Novo Nordisk Investigational Site
      • Rome, Italy, 00144
        • Novo Nordisk Investigational Site
      • Seoul, Korea, Republic of, 05510
        • Novo Nordisk Investigational Site
      • Mexico City, Mexico, 11560
        • Novo Nordisk Investigational Site
      • Riyadh, Saudi Arabia, 13315
        • Novo Nordisk Investigational Site
      • Madrid, Spain, 28033
        • Novo Nordisk Investigational Site
      • Taipei, Taiwan, 106
        • Novo Nordisk Investigational Site
      • Istanbul, Turkey, 34335
        • Novo Nordisk Investigational Site
      • Gatwick, United Kingdom, RH6 0PA
        • Novo Nordisk Investigational Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The respondent population will include Adolescents living with obesity (ALwO), Caregivers of ALwO, and HCPs treating adolescents who have obesity.

Description

Inclusion Criteria for Adolescents living with obesity:

  • Informed consent obtained by parent/legal guardian and ALwO before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Male or female, aged 12 to less than 18 years at the time of signing informed consent.
  • Lives in one of the participating countries: Italy, Spain, UK, Mexico, Colombia, Australia, Saudi Arabia, Turkey, South Korea, and Taiwan.
  • Has a current BMI-for-age (based on self-reported sex, age, height, and weight) greater than or equal to 95th percentile for age and sex based on charts appropriate locally for the country of residence.

Inclusion Criteria for Caregivers of Adolescents living with obesity:

  • Informed consent before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Male or female, age above or equal to 24 years at the time of signing informed consent.
  • Lives in one of the participating countries: Italy, Spain, UK, Mexico, Colombia, Australia, Saudi Arabia, Turkey, South Korea, and Taiwan.
  • Has an adolescent in the household with a current BMI-for-age (based on self-reported sex, age, height, and weight) greater than or equal to 95th percentile for age and sex based on charts appropriate locally for the country of residence.
  • Resides in the same household as the ALwO at least 50% of the time.
  • Is involved in the healthcare decisions of the ALwO.

Inclusion Criteria for Health Care Providers:

  • Informed consent before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Male or female, age above or equal to 18 years at the time of signing informed consent.
  • Is a physician.
  • Practices in one of the participating countries: Italy, Spain, UK, Mexico, Colombia, Australia, Saudi Arabia, Turkey, South Korea, and Taiwan
  • In clinical practice more than or equal to 2 years.
  • Spends at least 50% of time in direct patient care.
  • Has seen/treated at least ten adolescent patients (age 12 to less than 18 years) with obesity in a typical month (defined as BMI-for-age greater than or equal to 95th percentile for age and sex based on charts appropriate locally for the country of residence).

Exclusion Criteria for Adolescents living with obesity:

  • Previous participation in this study. Participation is defined as having given informed consent in this study.
  • Mental incapacity, unwillingness, inability, or language barriers precluding adequate understanding or cooperation.
  • Has had significant weight loss or weight gain due to major injury or illness/condition (e.g., cancer, accident, pregnancy) in the past 6 months.
  • Considers themselves to be extremely muscular.

Exclusion Criteria for Caregivers of Adolescents living with obesity:

  • Previous participation in this study. Participation is defined as having given informed consent in this study.
  • Mental incapacity, unwillingness, inability, or language barriers precluding adequate understanding or cooperation.
  • ALwO they care for has had significant weight loss or weight gain due to major injury or illness/condition (e.g., cancer, accident, pregnancy) in the past 6 months.
  • Considers the ALwO they care for to be extremely muscular.

Exclusion Criteria for Health Care Providers:

  • Previous participation in this study. Participation is defined as having given informed consent in this study.
  • Mental incapacity, unwillingness, inability, or language barriers precluding adequate understanding or cooperation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Adolescents Living with Obesity (ALwO)
Recruited from online, general population consumer panels
No treatment given
Health Care Providers (HCPs)
HCPs treating adolescents who have obesity
No treatment given
Caregivers
A parent or legal guardian of an adolescent with obesity
No treatment given

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attitudes about obesity, attitudes about people with obesity, and beliefs about the impact of obesity
Time Frame: At the time of survey response (Day 1)

5-point Likert scales (e.g., agreement, impact, frequency)

- Proportion of responses in each category will be reported.

At the time of survey response (Day 1)
Weight loss attempts in past year, motivations to lose weight, barriers to losing weight, and definition of successful weight loss/management
Time Frame: At the time of survey response (Day 1)

Yes/No; percentage of participants

Multi-select from defined list

- Percentage of respondents selecting an item or items will be reported.

At the time of survey response (Day 1)
History and frequency of conversations about weight, initiator of weight conversations, and responsibility for initiating weight conversations that occur between adolescents living with obesity/their caregivers and healthcare providers
Time Frame: At the time of survey response (Day 1)
Numeric entry; percentage of participants Single select from defined list; percentage of time each initiates Single select from defined list
At the time of survey response (Day 1)
Assessment of interactions between adolescents living with obesity/their caregivers and healthcare providers, reasons why obesity may not be discussed, frequency of obesity diagnosis, and frequency of follow-up appointments made to discuss obesity
Time Frame: At the time of survey response (Day 1)
5-point Likert scales Multi-select from defined list Yes/No; percentage of patients Yes/No; percentage of patients
At the time of survey response (Day 1)
Sources of information used to learn about obesity, healthy lifestyles, weight loss, and weight management
Time Frame: At the time of survey response (Day 1)
Multi-select from defined list
At the time of survey response (Day 1)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 23, 2021

Primary Completion (Actual)

December 13, 2021

Study Completion (Actual)

December 13, 2021

Study Registration Dates

First Submitted

August 6, 2021

First Submitted That Met QC Criteria

August 12, 2021

First Posted (Actual)

August 19, 2021

Study Record Updates

Last Update Posted (Actual)

February 2, 2022

Last Update Submitted That Met QC Criteria

February 1, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • DAS-003
  • U1111-1262-1190 (Other Identifier: World Health Organization)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

According to the Novo Nordisk disclosure commitment on novonordisk-trials.com

Drug and device information, study documents

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on No treatment given

Subscribe